CIBC World Market’s AbbVie ABBV Stock Holding History

CIBC World Market’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$146M	Sell	670,994 -23,421	-3%	-$5.2M	0.24%	77
2025 Q4	$159M	Buy	694,415 +37,143	+6%	+$8.46M	0.26%	70
2025 Q3	$152M	Buy	657,272 +60,635	+10%	+$12.3M	0.27%	72
2025 Q2	$111M	Buy	596,637 +13,180	+2%	+$2.45M	0.22%	77
2025 Q1	$122M	Sell	583,457 -8,074	-1%	-$1.57M	0.26%	75
2024 Q4	$105M	Buy	591,531 +113,324	+24%	+$20.8M	0.22%	79
2024 Q3	$94.4M	Sell	478,207 -52,124	-10%	-$9.73M	0.2%	87
2024 Q2	$91M	Sell	530,331 -12,534	-2%	-$2.08M	0.21%	79
2024 Q1	$98.9M	Sell	542,865 -8,651	-2%	-$1.49M	0.23%	74
2023 Q4	$85.5M	Sell	551,516 -40,656	-7%	-$5.93M	0.22%	82
2023 Q3	$88.3M	Sell	592,172 -54,299	-8%	-$7.97M	0.29%	68
2023 Q2	$87.1M	Sell	646,471 -50,566	-7%	-$7.42M	0.28%	67
2023 Q1	$111M	Sell	697,037 -86,845	-11%	-$13.3M	0.37%	53
2022 Q4	$127M	Sell	783,882 -28,012	-3%	-$4.3M	0.45%	49
2022 Q3	$109M	Sell	811,894 -87,969	-10%	-$12.6M	0.42%	51
2022 Q2	$138M	Sell	899,863 -1,107	-0.1%	-$169K	0.48%	39
2022 Q1	$146M	Sell	900,970 -13,301	-1%	-$1.93M	0.46%	46
2021 Q4	$124M	Buy	914,271 +71,938	+9%	+$8.5M	0.36%	60
2021 Q3	$90.9M	Buy	842,333 +38,961	+5%	+$4.45M	0.3%	68
2021 Q2	$90.5M	Buy	803,372 +42,069	+6%	+$4.74M	0.25%	71
2021 Q1	$82.4M	Buy	761,303 +241,596	+46%	+$25.8M	0.24%	79
2020 Q4	$55.7M	Buy	519,707 +49,121	+10%	+$4.72M	0.18%	98
2020 Q3	$41.2M	Buy	470,586 +9,050	+2%	+$852K	0.18%	89
2020 Q2	$45.3M	Buy	461,536 +39,152	+9%	+$3.45M	0.2%	80
2020 Q1	$32.2M	Buy	422,384 +60,459	+17%	+$5.15M	0.16%	97
2019 Q4	$32M	Buy	361,925 +18,808	+5%	+$1.56M	0.13%	103
2019 Q3	$26M	Sell	343,117 -76,382	-18%	-$5.24M	0.12%	105
2019 Q2	$30.5M	Buy	419,499 +10,890	+3%	+$856K	0.14%	107
2019 Q1	$32.9M	Buy	408,609 +44,132	+12%	+$3.61M	0.15%	97
2018 Q4	$33.6M	Sell	364,477 -106,658	-23%	-$9.38M	0.17%	90
2018 Q3	$44.6M	Sell	471,135 -624,484	-57%	-$59.2M	0.19%	80
2018 Q2	$102M	Buy	1,095,619 +569,237	+108%	+$55.6M	0.44%	43
2018 Q1	$49.8M	Buy	526,382 +211,811	+67%	+$23.3M	0.21%	77
2017 Q4	$30.4M	Sell	314,571 -11,633	-4%	-$1.1M	0.14%	87
2017 Q3	$29M	Sell	326,204 -48,810	-13%	-$3.72M	0.14%	80
2017 Q2	$27.2M	Buy	375,014 +73,615	+24%	+$4.95M	0.12%	97
2017 Q1	$19.6M	Sell	301,399 -37,341	-11%	-$2.35M	0.06%	124
2016 Q4	$21.2M	Sell	338,740 -3,167	-0.9%	-$193K	0.07%	87
2016 Q3	$21.6M	Buy	341,907 +29,501	+9%	+$1.91M	0.08%	76
2016 Q2	$19.3M	Buy	312,406 +2,989	+1%	+$182K	0.09%	67
2016 Q1	$17.7M	Buy	309,417 +42,795	+16%	+$2.39M	0.08%	63
2015 Q4	$15.8M	Buy	266,622 +75,366	+39%	+$4.34M	0.08%	68
2015 Q3	$10.4M	Sell	191,256 -86,618	-31%	-$5.64M	0.05%	82
2015 Q2	$18.7M	Buy	277,874 +131,092	+89%	+$8.56M	0.08%	61
2015 Q1	$8.59M	Buy	146,782 +5,443	+4%	+$329K	0.04%	104
2014 Q4	$9.25M	Buy	141,339 +115,049	+438%	+$7.25M	0.03%	89
2014 Q3	$1.52M	Buy	26,290 +6,118	+30%	+$340K	0.01%	329
2014 Q2	$1.14M	Sell	20,172 -507	-2%	-$26.6K	﹤0.01%	377
2014 Q1	$1.06M	Sell	20,679 -261	-1%	-$13.2K	﹤0.01%	378
2013 Q4	$1.11M	Sell	20,940 -23,585	-53%	-$1.16M	﹤0.01%	343
2013 Q3	$1.99M	Buy	44,525 +3,480	+8%	+$154K	0.01%	234
2013 Q2	$1.7M	Buy	+41,045	New	+$1.8M	0.01%	232

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CIBC World Market's ABBV Position: Q1 2026 in Review

CIBC World Market reduced its AbbVie (ABBV) stake by 3.4% in Q1 2026, selling an estimated $5.2M and leaving 670,994 shares worth $146M. The position accounts for 0.24% of the portfolio, ranked #77.

CIBC World Market first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $159M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

CIBC World Market held 670,994 shares of AbbVie worth $146M as of Q1 2026.
CIBC World Market sold 23,421 AbbVie shares in Q1 2026, an estimated $5.2M.
AbbVie made up 0.24% of CIBC World Market's portfolio in Q1 2026, its #77 holding.
CIBC World Market first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
CIBC World Market's AbbVie position peaked at $159M in Q4 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.